LOS ANGELES, CA–(Marketwire – November 13, 2009) – Reed’s, Inc. (
Mr. Neal Cohane, Senior VP of Marketing and Sales for Reed’s, Inc. will be attending the event, staffing a booth where he will be distributing samples of Reed’s Ginger Brews and Ginger Candy, and product literature discussing the benefits of ginger for chemotherapy related nausea. “This event will attract a diverse cross-section of Oncology professionals, including Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers, Pharmacists and other non-physician members of the oncology clinical care team. These are ‘front line’ professionals who often counsel their patients more closely than even the physicians themselves,” stated Mr. Cohane.
Reed’s attended the American Society of Clinical Oncology (ASCO) 2009 Annual Meeting in Orlando, Florida earlier this year. At that time, Reed’s reported on a recently released study, funded by the National Cancer Institute, which found that ginger can successfully treat post-chemo nausea in cancer patients. Some of the findings were:
— Up to 70% of patients become nauseated after chemo, according to the study of 644 people
— According to the study’s author, “Although drugs… can prevent vomiting, they don’t always relieve nausea”
— Ginger reduced patients’ nausea levels by half, according to the study
— The most effective doses were 1 gram and 0.5 gram a day, which are equal to half a teaspoon or one-quarter of a teaspoon of ground ginger, according to the study
— Reed’s Ginger Brews contain between 8 and 26 grams of ginger per serving
— Reed’s is the ONLY commercial soft drink manufacturer using fresh, whole ginger in its products
— Significantly, ginger caused no side effects, according to the study
Chris Reed, Founder and CEO of Reed’s commented then that, “We’ve known for years that people have been using our Ginger Brews for post-chemo nausea, we’ve even been contacted by doctors who have had cancer and have told us they drank our Reed’s Ginger Brew to relieve their own post-chemo nausea. With 8 to 26 grams of fresh ginger per bottle these drinks work quite well for any kind of nausea; from motion sickness to morning sickness to post chemo nausea. In fact, in medical tests ginger beats Dramamine, which is one of the top over the counter nausea medications.”
A Food Network Finds video describing Reed’s brewing process and use of fresh ginger is available at:
The study’s co-author, Julie Ryan, assistant professor of dermatology and radiation oncology at the University of Rochester Medical Center, commented in the study, “That’s why we’re so excited. This is something that people have access to, that won’t harm them.”
Reed added, “Other cultures have been using ginger as a folk remedy for thousands of years. It was only a matter of time until ginger would be tested for its effectiveness in treating post-chemo nausea.” Richard Schilsky, Oncology Society President, who wasn’t involved in the study, describes the trial’s results as “conclusive.”
The Chemotherapy Foundation Symposium is a non-profit organization, the Foundation supports selected laboratory and clinical research projects at major New York metropolitan medical centers, symposia for the profession, and publishes a series of free informative booklets for the profession and the public. More information can be found at the Foundation’s website: http://www.chemotherapyfoundationsymposium.org/
About Reed’s, Inc.
Reed’s, Inc. makes the top selling sodas in natural food markets nationwide and is currently selling in 10,500 supermarkets in natural foods and mainstream. Its six award-winning non-alcoholic Ginger Brews are unique in the beverage industry, being brewed, not manufactured and using fresh ginger, spices and fruits in a brewing process that predates commercial soft drinks.
In addition, the Company owns the top selling root beer line in natural foods, the Virgil’s Root Beer product line, and the top selling cola line in natural foods, the China Cola product line. Recently, Reed’s added the Sonoma Sparkler brands to its line, a celebration drink with an established customer base. Other product lines include: Reed’s Ginger Candies and Reed’s Ginger Ice Creams.
Reed’s products are sold through specialty gourmet and natural food stores, mainstream supermarket chains, retail stores and restaurants nationwide, and in Canada. For more information about Reed’s, please visit the company’s website at: http://www.reedsgingerbrew.com or call 800-99-REEDS.
Follow Reed’s on Twitter at: http://www.twitter.com/reedsgingerbrew
Reed’s Delicious bookmarks at: http://www.delicious.com/reedsinc
Reed’s Facebook Fan Page at: http://www.facebook.com/pages/Reeds-Ginger-Brew-and-Virgils-Natural-Sodas/57143529039?ref=nf
Subscribe to Reed’s RSS feed at: http://www.irthcommunications.com/REED_rss.xml
More information can be found at: http://www.irthcommunications.com/clients_REED.php
SAFE HARBOR STATEMENT
Some portions of this press release, particularly those describing Reed’s goals and strategies, contain “forward-looking statements.” These forward-looking statements can generally be identified as such because the context of the statement will include words, such as “expects,” “should,” “believes,” “anticipates” or words of similar import. Similarly, statements that describe future plans, objectives or goals are also forward-looking statements. While Reed’s is working to achieve those goals and strategies, actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These risks and uncertainties include difficulty in marketing its products and services, maintaining and protecting brand recognition, the need for significant capital, dependence on third party distributors, dependence on third party brewers, increasing costs of fuel and freight, protection of intellectual property, competition and other factors, any of which could have an adverse effect on the business plans of Reed’s, its reputation in the industry or its expected financial return from operations and results of operations. In light of significant risks and uncertainties inherent in forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by Reed’s that they will achieve such forward-looking statements. For further details and a discussion of these and other risks and uncertainties, please see our most recent reports on Form 10-KSB and Form 10-Q, as filed with the Securities and Exchange Commission, as they may be amended from time to time. Reed’s undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.